Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$11K Sell
542
-517
-49% -$11.9K ﹤0.01% 4292
2019
Q3
$24K Sell
1,059
-134
-11% -$3.71K ﹤0.01% 3836
2019
Q2
$42K Sell
1,193
-20,710
-95% -$663K ﹤0.01% 3496
2019
Q1
$690K Buy
21,903
+21,198
+3,007% +$618K 0.01% 1367
2018
Q4
$17K Buy
705
+28
+4% +$719 ﹤0.01% 3906
2018
Q3
$20K Buy
677
+118
+21% +$2.21K ﹤0.01% 3891
2018
Q2
$7K Buy
559
+362
+184% +$4.15K ﹤0.01% 4230
2018
Q1
$2K Buy
197
+154
+358% +$949 ﹤0.01% 4671
2017
Q4
$0 Buy
+43
New +$268 ﹤0.01% 4964

Other funds holding CDNA

Advisor Group's CDNA Position: Q4 2019 in Review

Advisor Group reduced its CareDx (CDNA) stake by 49% in Q4 2019, selling an estimated $11.9K and leaving 542 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #4292.

Advisor Group first reported a position in CDNA in Q4 2017 and has held it in 9 quarters since. The position peaked at $690K in Q1 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

  • Advisor Group held 542 shares of CareDx worth $11K as of Q4 2019.
  • Advisor Group sold 517 CareDx shares in Q4 2019, an estimated $11.9K.
  • CareDx made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4292 holding.
  • Advisor Group first reported a position in CareDx in Q4 2017 and has held it in 9 quarters since.
  • Advisor Group's CareDx position peaked at $690K in Q1 2019.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.